It is the internal testing website that you are visiting. Please go to our official customer website (www.myplaniq.com).
Find A Portfolio/Ticker
Comparison Box
FBDIX: FRANKLIN BIOTECHNOLOGY DISCOVERY FUND CLASS A (MUTUAL FUND)
Basic Info 169.15 4.05(2.34%) June 05
| Asset Class: | Health |
| MyPlanIQ Rating: | (43%) |
| Start Date: | 09/16/1997 |
| Last Dividend Date: | 12/22/2025 |
| 12-Mo. Yield | 15.81% |
| Expenses | 1.04% |
| Sign up to get fund ranking change alerts | |
Performance Analytics (As of 06/05/2026)
| Last 1 Week* | YTD*(2026) | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Inception** | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return(%) | -5.4 | 2.1 | 62.8 | 22.6 | 6.1 | 6.3 | 10.7 | 10.0 | 9.8 | 52.7 | 4.1 | 18.4 | -12.7 | -27.7 | 13.6 | 35.0 | -15.8 | 18.8 | -17.1 | 5.7 | 33.8 | 68.7 | 29.3 | 8.1 | 17.3 | 11.8 | -10.6 | -1.6 | 5.0 | 5.6 | 12.0 | 43.5 | -42.5 | -20.5 | 46.6 | 97.9 | 10.7 | -6.9 |
| Sharpe Ratio | NA | 0.09 | 2.59 | 0.87 | 0.15 | 0.18 | NA | NA | 0.3 | 2.03 | 0.02 | 0.81 | -0.48 | -1.1 | 0.35 | 1.47 | -0.65 | 1.01 | -0.56 | 0.2 | 1.21 | 3.23 | 1.64 | 0.33 | 0.89 | 0.57 | -0.36 | -0.3 | 0.1 | 0.17 | 0.48 | 1.7 | -1.16 | -0.56 | 0.77 | 3.96 | 0.31 | -1.04 |
| Draw Down(%) | NA | 9.2 | 9.2 | 28.6 | 46.9 | 55.3 | NA | NA | 71.4 | 22.1 | 13.9 | 13.3 | 29.4 | 37.6 | 28.3 | 17.4 | 29.5 | 13.0 | 29.8 | 28.4 | 24.1 | 12.1 | 12.6 | 22.2 | 18.7 | 16.9 | 31.7 | 12.6 | 21.2 | 17.3 | 24.5 | 11.3 | 50.1 | 39.7 | 47.9 | 17.5 | 35.2 | 18.8 |
| Standard Deviation(%) | NA | 26.4 | 23.2 | 22.3 | 23.8 | 25.5 | NA | NA | 27.3 | 24.7 | 19.5 | 18.3 | 29.4 | 25.3 | 37.7 | 22.9 | 26.5 | 18.1 | 31.2 | 29.2 | 27.8 | 21.2 | 18.1 | 24.6 | 19.3 | 20.7 | 31.8 | 15.7 | 16.6 | 20.0 | 22.8 | 25.2 | 37.6 | 41.4 | 55.1 | 23.9 | 23.8 | 24.3 |
| Treynor Ratio | NA | 0.02 | 0.54 | 0.16 | 0.03 | 0.04 | NA | NA | 0.07 | 0.47 | 0.0 | 0.12 | -0.11 | -0.25 | 0.12 | 0.25 | -0.12 | 0.14 | -0.1 | 0.04 | 0.2 | 0.44 | 0.21 | 0.07 | 0.13 | 0.13 | -0.12 | -0.04 | 0.01 | 0.02 | 0.07 | 0.31 | -0.3 | -0.12 | 0.29 | 0.92 | 0.07 | -0.19 |
| Alpha | NA | 0.05 | 0.12 | 0.07 | 0.01 | 0.0 | NA | NA | -0.01 | 0.11 | 0.03 | 0.05 | -0.04 | -0.18 | 0.01 | 0.02 | -0.06 | 0.0 | 0.0 | -0.04 | -0.04 | -0.01 | 0.03 | -0.02 | 0.04 | -0.02 | 0.04 | -0.02 | -0.03 | -0.06 | -0.01 | 0.02 | -0.13 | -0.01 | -0.07 | 0.25 | -0.09 | -0.13 |
| Beta | NA | 1.28 | 1.12 | 1.18 | 1.17 | 1.2 | NA | NA | 1.26 | 1.06 | 1.27 | 1.21 | 1.24 | 1.12 | 1.09 | 1.34 | 1.41 | 1.28 | 1.66 | 1.46 | 1.71 | 1.57 | 1.39 | 1.19 | 1.29 | 0.91 | 0.97 | 1.14 | 1.35 | 1.62 | 1.65 | 1.37 | 1.46 | 1.89 | 1.49 | 1.03 | 0.97 | 1.3 |
| RSquared | NA | 0.58 | 0.52 | 0.57 | 0.56 | 0.58 | NA | NA | 0.53 | 0.55 | 0.58 | 0.6 | 0.72 | 0.25 | 0.65 | 0.62 | 0.7 | 0.49 | 0.74 | 0.72 | 0.63 | 0.6 | 0.58 | 0.78 | 0.74 | 0.66 | 0.76 | 0.62 | 0.56 | 0.49 | 0.53 | 0.58 | 0.61 | 0.49 | 0.27 | 0.42 | 0.42 | 0.64 |
| Yield(%) | N/A | 0.0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 14.8 | 9.1 | 0.0 | 0.1 | 0.6 | 0.0 | 11.5 | 3.0 | 2.7 | 3.8 | 8.1 | 5.1 | 10.3 | 0.1 | 14.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.3 | 1.8 | 0.2 |
| Dividend Growth(%) | N/A | -100.0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 53.0 | N/A | -100.0 | -86.1 | N/A | -100.0 | 211.3 | 26.5 | -39.4 | -56.9 | 106.6 | -24.2 | 12643.5 | -99.3 | N/A | N/A | N/A | N/A | N/A | -100.0 | N/A | N/A | N/A | N/A | -100.0 | 193.8 | -84.8 | 795.7 | N/A |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 09/15/1997
Calculate Performance
Start date (MM/dd/yyyy)
End date (MM/dd/yyyy)
|
View Historical Data in an advanced chart |
Use MyPlanIQ Comparison to compare with multiple funds or portfolios |
See Health Asset Class Trend Rankings |
Top Rated Funds in Health
Best Mutual Funds
- VGHCX (VANGUARD HEALTH CARE FUND INVESTOR SHARES) (97%)
- HGHAX (THE HARTFORD HEALTHCARE FUND CLASS A) (79%)
- FSMEX (MEDICAL EQUIPMENT AND SYSTEMS PORTFOLIO MEDICAL EQUIPMENT AND SYSTEMS PORTFOLIO) (78%)
- FBIOX (BIOTECHNOLOGY PORTFOLIO BIOTECHNOLOGY PORTFOLIO) (77%)
- FBTIX (FIDELITY ADVISOR BIOTECHNOLOGY FUND CLASS I) (77%)
- FPHAX (PHARMACEUTICALS PORTFOLIO PHARMACEUTICALS PORTFOLIO) (75%)
- FSHCX (HEALTH CARE SERVICES PORTFOLIO HEALTH CARE SERVICES PORTFOLIO) (74%)
- FSPHX (HEALTH CARE PORTFOLIO HEALTH CARE PORTFOLIO) (74%)
- FHCIX (FIDELITY ADVISOR HEALTH CARE FUND CLASS I) (73%)
- SHSSX (BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO INSTITUTIONAL) (66%)
Best ETFs
- DRGS (RBS Global Big Pharma ETN) (100%)
- XLV (Health Care Select Sector SPDR Fund) (96%)
- BBH (VanEck Biotech ETF) (94%)
- IBB (iShares Biotechnology ETF) (94%)
- PPH (VanEck Pharmaceutical ETF) (94%)
- FBT (First Trust NYSE Arca Biotechnology Index Fund) (91%)
- FXH (First Trust Health Care AlphaDEX Fund) (90%)
- IHE (iShares U.S. Pharmaceuticals ETF) (88%)
- IHF (iShares U.S. Healthcare Providers ETF) (88%)
- IHI (iShares U.S. Medical Devices ETF) (88%)
Best Closed End Funds
- BME (BlackRock Health Sciences Trust) (100%)
- GRX (Gabelli Healthcare & WellnessRx Trust) (99%)
- HQH (Tekla Healthcare Investors) (98%)
- HQL (Tekla Life Sciences Investors) (98%)
